Purchases and Sales Made in Q1 2024 in Nuvalent, Inc. (NUVL)
This table provides information about the institutional ownership of Nuvalent, Inc. (NUVL) during Q1 2024. The information is specifically focused on institutions that hold shares of Nuvalent, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 14, 2024
Q1 2024
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-25.4K- 22.52% |
$1.84M - $2.26M
|
87.5K
$7.5M
|
|
May 15, 2024
Q1 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-27.2K- 43.26% |
$1.96M - $2.42M
|
35.6K
$3.05M
|
|
May 14, 2024
Q1 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-28.9K- 43.76% |
$2.09M - $2.57M
|
37.2K
$3.18M
|
|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-30.4K- 55.65% |
$2.2M - $2.71M
|
24.2K
$2.08M
|
|
May 14, 2024
Q1 2024
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-35.3K- 18.26% |
$2.55M - $3.14M
|
158K
$13.5M
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-40.3K- 18.41% |
$2.91M - $3.58M
|
178K
$15.3M
|
|
May 08, 2024
Q1 2024
|
Td Asset Management Inc
|
SELL
|
- |
-41.6K- 76.36% |
$3.01M - $3.7M
|
12.9K
$1.1M
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-50.6K- 59.7% |
$3.66M - $4.5M
|
34.1K
$2.93M
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-56.7K- 64.3% |
$4.1M - $5.04M
|
31.5K
$2.69M
|
|
May 15, 2024
Q1 2024
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-58.1K- 29.18% |
$4.2M - $5.17M
|
141K
$12.1M
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-88.5K- 32.39% |
$6.4M - $7.87M
|
185K
$15.8M
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-88.5K- 32.39% |
$6.4M - $7.87M
|
185K
$15.8M
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-91K- 32.07% |
$6.58M - $8.1M
|
193K
$16.5M
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-99.3K- 47.46% |
$7.18M - $8.83M
|
110K
$9.41M
|
|
May 15, 2024
Q1 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-135K- 4.61% |
$9.73M - $12M
|
2.78M
$238M
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-157K- 60.64% |
$11.3M - $13.9M
|
102K
$8.71M
|
|
May 15, 2024
Q1 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-175K- 39.0% |
$12.7M - $15.6M
|
275K
$23.5M
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-187K- 11.0% |
$13.5M - $16.7M
|
1.51M
$130M
|
|
May 15, 2024
Q1 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-194K- 59.96% |
$14M - $17.2M
|
129K
$11.1M
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-202K- 52.24% |
$14.6M - $18M
|
185K
$15.8M
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-248K- 22.44% |
$18M - $22.1M
|
858K
$73.5M
|
|
May 15, 2024
Q1 2024
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-265K- 28.24% |
$19.2M - $23.6M
|
673K
$57.7M
|
|
May 15, 2024
Q1 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-880K- 24.6% |
$63.7M - $78.3M
|
2.7M
$231M
|